Brought to you by 
Boston Scientific acquires urology device company NxThera for $306mm, plus earn-outs
27 Mar 2018
Executive Summary
Boston Scientific Corp. agreed to buy private urology device firm NxThera Inc. for up to $406mm. Through its participation in NxThera's December 2015 Series D round, BSC already has an undisclosed minority stake in the company.
Deal Industry
- Medical Devices
-
Medical Devices
- Radiofrequency Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boston Scientific acquires urology device company NxThera for $306mm, plus earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice